VIP (Vasoactive Intestinal Peptide)

What it is?

VIP is a naturally occurring neuropeptide hormone studied for its broad regulatory roles across vascular tone, immune modulation, gastrointestinal function, and neuro-circadian signalling. It is positioned for multi-system protocols where neuroimmune balance and smooth-muscle regulation are core endpoints.

Dripfy Advantage

• Receptor engagement: Binds to VIP receptors (commonly VPAC receptor pathways), influencing smooth-muscle relaxation signalling.
• Vascular and smooth-muscle modulation: Supports vasodilatory and smooth-muscle relaxation dynamics relevant to circulation and GI motility endpoints.
• Immune modulation: Associated with regulation of immune-cell activity and inflammatory signalling balance.
• Neuro-circadian interface: Frequently studied for involvement in circadian regulation and neuronal signalling pathways impacting sleep and rhythm stability.

Clinical Applications & Therapeutic Potential

• Digestive and motility endpoints: Potential support for gastrointestinal function markers and smooth-muscle regulation outcomes.
• Circulatory health frameworks: Potential improvements in vascular tone markers and circulation-related endpoints (context-dependent).
• Anti-inflammatory signalling: Positioned for reduced inflammatory response markers and improved immune balance profiles.
• Sleep and circadian regulation: Potential support for circadian rhythm stability and sleep-quality endpoints via neuropeptide signalling pathways.

Composition & Formulation

• Peptide/Class: VIP neuropeptide (vasoactive / neuroimmune signalling peptide)
• Format: Injectable research formulation